Defence systems drive accessory genome interactions in Pseudomonas aeruginosa
Chong CE +10 more
europepmc +1 more source
Effect of 5-fluorouracil on <i>Pseudomonas aeruginosa</i>: impact on virulence, biofilm formation, and bacterial growth. [PDF]
Front MicrobiolNiazy AA, Alrashed MM, Niazy AA.
europepmc +1 more source
Veterinary Clinics as Reservoirs for <i>Pseudomonas aeruginosa</i>: A Neglected Pathway in One Health Surveillance. [PDF]
Antibiotics (Basel)Nadăş GC +3 more
europepmc +1 more source
Diversity and Role of Prophages in <i>Pseudomonas aeruginosa</i>: Resistance Genes and Bacterial Interactions. [PDF]
Genes (Basel)Xavier KVM +6 more
europepmc +1 more source
Ceftazidime-avibactam for the treatment of Pseudomonas aeruginosa: a plain language summary. [PDF]
Future MicrobiolKiratisin P, Kempf M, Stone G, Utt E.
europepmc +1 more source
Synthesis of polypyrrole/cellulose nanocrystals disks for removal of pyocyanin metabolite biomarker released by Pseudomonas aeruginosa. [PDF]
PLoS OneEl-Said WA +5 more
europepmc +1 more source
Combatting <i>Pseudomonas aeruginosa</i> with β-Lactam Antibiotics: A Revived Weapon? [PDF]
Antibiotics (Basel)Zhao DW, Lohans CT.
europepmc +1 more source
Pseudomonas aeruginosa in Bronchiectasis [PDF]
Seminars in Respiratory and Critical Care Medicine, 2021 Abstract Pseudomonas aeruginosa (PA) in patients with bronchiectasis (BE) is associated with a poor outcome and quality of life, and its presence is considered a marker of disease severity. This opportunistic pathogen is known for its ability to produce biofilms on biotic or abiotic surfaces and to survive environmental stress exerted by ...
Rosanel Amaro +3 more
openaire +2 more sources